- The Number That Matters: 500 on a 200-800 Scale
- Why 500 Is Not a Percentage
- What You Sit For: 300 Questions Over Seven Hours
- Where Your Points Come From: The 17 Content Areas
- Building a Score Strategy Around the Blueprint
- Fees, Late Surcharges, and the Score Audit Window
- Eligibility Checks That Affect Your Test Attempt
- After You Pass: Ten-Year Certification and OCC
- Keeping AOBIM and ABIM Expectations Separate
- Frequently Asked Questions
- Passing the AOBIM Oncology written exam requires a scaled score of at least 500 on the AOA 200-800 scale.
- A scaled 500 is not a raw percentage of correct answers, so stop trying to convert it to one.
- The initial exam has 300 multiple-choice questions and runs seven hours.
- Hematologic malignancies (15-19%) and Genitourinary tumors (10-14%) carry the heaviest blueprint ranges.
The Number That Matters: 500 on a 200-800 Scale
If you are preparing for the osteopathic subspecialty certification in Oncology offered through the American Osteopathic Board of Internal Medicine (AOBIM), there is one passing threshold to know: a scaled score of at least 500 on the AOA 200-800 scale. That is the standard for the initial written examination. This article is about that credential specifically, not the ABIM Medical Oncology exam and not a combined hematology-oncology examination.
The simplicity of the number is deceptive. Many candidates see "500" and instinctively think "62.5% of the way up from 200 to 800," or worse, "I need about half the questions right." Neither framing is reliable, and building a study plan on either one can leave you either over-anxious or under-prepared. The sections below explain what the scale actually means for how you should study.
Why 500 Is Not a Percentage
A scaled score is a transformed score. The raw number of questions you answer correctly is converted onto the 200-800 reporting scale so that results remain comparable across different forms of the exam. The consequence is straightforward: 500 is not a raw percentage of correct answers, and no one should tell you "you need X questions right out of 300" unless that figure comes directly from the certifying body.
What this means for your practice
- Do not treat practice-test percentages as score predictions. A 70% on a question bank tells you about your command of that bank's content, not your scaled outcome.
- Do not hunt for a "magic raw cutoff." Any cutoff you find in a forum thread is anecdotal and unverified.
- Aim for broad competence, not a narrow target. Because the exam covers 17 content areas, the safest strategy is to avoid weak domains rather than to optimize a few.
For a candid look at how candidates experience the exam's difficulty, see our guide on how hard the Oncology exam is. For what the available outcome data does and does not tell you, read the Oncology pass rate analysis.
What You Sit For: 300 Questions Over Seven Hours
The initial written examination consists of 300 multiple-choice questions administered across seven hours. That is a long, endurance-heavy exam, and stamina is part of the passing equation. Working through that many items means your accuracy in hour six matters as much as your accuracy in hour one.
A rough pacing mindset helps: with 300 items and seven hours, you have just over a minute per question on average, before accounting for breaks. Oncology questions tend to be clinical-vignette driven, so reading time can eat into that quickly. Practice sessions should include long, uninterrupted blocks so that the length of the real exam is not a surprise.
Where Your Points Come From: The 17 Content Areas
You reach 500 by accumulating correct answers across the official content areas, each of which has a published percentage range. These are ranges, not fixed counts, and they should be read as ranges. Do not substitute midpoints, and do not import a blueprint from another board. For a deeper walk-through of each area, see our complete guide to all 17 Oncology content areas.
| Content Area | Official Range |
|---|---|
| Hematologic malignancies | 15-19% |
| Genitourinary tumors | 10-14% |
| Gastrointestinal tumors | 6-10% |
| Chemotherapy toxicity | 6-10% |
| Breast tumors | 5-9% |
| Supportive care/palliative/ethics | 5-9% |
| Thoracic tumors | 4-8% |
| Paraneoplastic syndromes | 4-8% |
| Gynecologic tumors | 3-7% |
| Pharmacology/cancer biology/cancer genetics | 2-6% |
| Pancreatic/liver cancer | 2-6% |
| Prevention/screening | 2-6% |
| Skin cancer | 1-5% |
| Head and neck cancer | 1-5% |
| Bone/soft tissue/sarcoma | 1-5% |
| Opportunistic infection | 1-4% |
| Cancer trials | 1-3% |
Reading the table like a score strategist
Two content areas, Hematologic malignancies and Genitourinary tumors, together account for a large share of the exam by their upper and lower bounds. That does not mean you can ignore the rest. It means these two are where a weakness is most expensive and where mastery is most rewarded.
Hematologic malignancies (15-19%)
The single largest area. Candidates should be fluent in diagnosis, classification, risk stratification, and treatment selection across the leukemias, lymphomas, and plasma cell disorders.
- Distinguish disease subtypes by presentation and diagnostic findings
- Know first-line and relapse treatment logic, not just drug names
- Recognize disease- and therapy-related complications
Genitourinary tumors (10-14%)
The second-largest area. Expect questions on prostate, bladder, kidney, and testicular malignancies.
- Staging-driven management decisions
- Systemic therapy sequencing in advanced disease
- Surveillance and follow-up principles
Chemotherapy toxicity (6-10%) and Supportive care/palliative/ethics (5-9%)
These two areas reward clinical judgment. Together they make up a meaningful block of the exam and cut across every tumor type.
- Recognize and manage organ-specific drug toxicities
- Symptom control, goals-of-care communication, and ethical decision-making
Smaller areas that still count
Cancer trials (1-3%), Opportunistic infection (1-4%), Skin cancer, Head and neck cancer, and Bone/soft tissue/sarcoma (each 1-5%) are low-weight individually, but together they add up. Skipping all of them leaves a real gap in your total.
Building a Score Strategy Around the Blueprint
Because the passing standard is a scaled 500 rather than a visible raw target, the practical goal is to be reliably competent everywhere and strong in the heavy areas. Below is one way to sequence preparation using the blueprint. For a broader foundation, our Oncology study guide goes deeper on resources and approach.
Heavy-weight foundations
- Start with Hematologic malignancies, since it carries the largest range
- Follow with Genitourinary tumors
- Take a short diagnostic block on each to find weak subtopics
Mid-weight solid tumors and toxicity
- Gastrointestinal tumors, Breast tumors, Thoracic tumors, Gynecologic tumors
- Chemotherapy toxicity alongside each tumor type's standard regimens
- Supportive care/palliative/ethics, which pairs naturally with toxicity management
Low-weight sweep and integration
- Paraneoplastic syndromes, Pharmacology/cancer biology/cancer genetics, Prevention/screening
- Pancreatic/liver, Skin, Head and neck, Bone/soft tissue/sarcoma
- Opportunistic infection and Cancer trials
- Full-length mixed blocks to rehearse the seven-hour format
Treat this as a template to adjust, not a prescription. If your fellowship gave you deep exposure to solid tumors but limited hematology, flip the order. The principle is to attack your largest weighted weaknesses first, because those are the ones that can pull your scaled score below 500.
Key Takeaway
Since the exam is scored on a scaled basis, avoid "gaming" the blueprint by dropping low-weight areas. Aim for competence in all 17 content areas and mastery in the two largest. A short, targeted review of the small areas costs little and protects your total.
Fees, Late Surcharges, and the Score Audit Window
The passing score is only part of the picture; the financial and procedural mechanics matter too. All amounts below are in USD and come from the certification facts for this exam.
| Item | Amount (USD) |
|---|---|
| Initial examination fee | $800 |
| Late surcharge | $240 |
| Examination plus late surcharge (calculated total) | $1,040 |
| Optional score audit | $200 |
The practical lesson: registering on time saves $240 compared with registering late. If you miss the standard window, the examination plus late surcharge comes to $1,040. For a fuller view of costs beyond the exam fee, see our Oncology certification cost breakdown, and check the current schedule on our Oncology exam dates page before you commit.
Understanding the score audit
If your result is close to the line, or simply surprising, an optional score audit is available for $200. The key constraint is timing: a score audit must be requested within one month of the results. Do not let that deadline slip while you decide. If you think you may want an audit, mark the date the moment results arrive.
Eligibility Checks That Affect Your Test Attempt
You cannot reach the scoring question until you are approved to sit. Eligibility for the initial Oncology certification includes AOA board certification in internal medicine, two years of an ACGME-accredited or AOA-recognized Oncology or Hematology/Oncology fellowship, an active medical license, ethical standing, a completed application, and program-director verification. A qualifying three-year combined or separate hematology/oncology training route can support applications for the separate Hematology and Oncology examinations.
Application problems, such as a missing verification from a program director, are a common reason candidates find themselves paying the late surcharge. Start the paperwork early. Our Oncology requirements guide walks through each prerequisite in more detail.
After You Pass: Ten-Year Certification and OCC
Earning a scaled 500 or higher is the beginning of a certification cycle, not the end. Certification has a ten-year term, conditional on Osteopathic Continuous Certification (OCC). For the 2025-2027 cycle, time-limited diplomates require:
- 60 CME credits over three years, including 15 Category 1 and/or Category 1-A credits
- One quality-improvement activity attestation per three-year cycle
- Active licensure
Oncology remains on the remotely proctored subspecialty OCC examination route offered annually in August. Diplomates may begin that examination two years before certificate expiration, and a successful early renewal extends from the existing certificate's expiration date. Keep this separate in your mind from the primary internal-medicine longitudinal assessment, since the Oncology OCC pathway is its own track. If you are weighing whether the whole investment pays off, see whether the Oncology certification is worth it and our salary guide.
Keeping AOBIM and ABIM Expectations Separate
Candidates sometimes carry assumptions from the ABIM Medical Oncology exam into this one. Do not. The passing standard discussed here, a scaled 500 on the AOA 200-800 scale, belongs to the AOBIM Oncology examination. Blueprint weights, question counts, fees, and policies from another board should not be used to plan for this exam. If a resource quotes a different domain breakdown, a different fee, or a different passing standard, verify it against the official AOBIM pages before trusting it.
Key Takeaway
Anchor everything to the AOBIM Oncology outline: 300 questions, seven hours, 17 content areas with official ranges, and a scaled passing score of 500. When in doubt, check the official AOBIM Oncology pages rather than a secondhand summary.
To test yourself against that outline, work through original practice items on the main practice test site, and pair your practice with the one-page Oncology cheat sheet for last-week review.
Frequently Asked Questions
Passing requires a scaled score of at least 500 on the AOA 200-800 scale. This applies to the initial written examination for certification in Oncology through the American Osteopathic Board of Internal Medicine.
No. A scaled score of 500 is not a raw percentage of correct answers. Raw performance is converted to the 200-800 scale, so you cannot translate 500 directly into a number of correct questions out of 300.
The initial written examination contains 300 multiple-choice questions and lasts seven hours. Plan your practice around sustained, long-block sessions to build stamina.
The initial examination fee is $800 and the late surcharge is $240, so examination plus late surcharge totals $1,040. An optional score audit costs $200 and must be requested within one month of the results.
Hematologic malignancies is the largest area at 15-19%, followed by Genitourinary tumors at 10-14%. Gastrointestinal tumors and Chemotherapy toxicity each carry 6-10%. Prioritize these, but still review every area because a scaled score reflects overall performance across the full blueprint.